Ganguly, S.S.; Daft, P.G.; Cao, J.; Meng, X.; Zhong, Z.A.; Vander Ark, A.; Meadows, A.; Madaj, Z.; Williams, B.; Li, X.
Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions. Cancers 2018, 10, 463.
https://doi.org/10.3390/cancers10120463
AMA Style
Ganguly SS, Daft PG, Cao J, Meng X, Zhong ZA, Vander Ark A, Meadows A, Madaj Z, Williams B, Li X.
Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions. Cancers. 2018; 10(12):463.
https://doi.org/10.3390/cancers10120463
Chicago/Turabian Style
Ganguly, Sourik S., Paul G. Daft, Jingchen Cao, Xiangqi Meng, Zhendong A. Zhong, Alexandra Vander Ark, Austin Meadows, Zach Madaj, Bart Williams, and Xiaohong Li.
2018. "Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions" Cancers 10, no. 12: 463.
https://doi.org/10.3390/cancers10120463
APA Style
Ganguly, S. S., Daft, P. G., Cao, J., Meng, X., Zhong, Z. A., Vander Ark, A., Meadows, A., Madaj, Z., Williams, B., & Li, X.
(2018). Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions. Cancers, 10(12), 463.
https://doi.org/10.3390/cancers10120463